Results 181 to 190 of about 568,486 (233)

The Behavior of the External Limiting Membrane and Ellipsoid Zone in Diabetic Macular Edema: A Population AI-Assisted Optical Coherence Tomography Study. [PDF]

Invest Ophthalmol Vis Sci
Midena E, Lupidi M, Frizziero L, Midena G, Pilotto E, Toto L, Cicinelli MV, Veritti D, Covello G, Lattanzio R, Figus M, Danieli L, Borrelli E, Reibaldi M, Tognetto D, Inferrera L, Donati S, Rossi S, Melillo P, Lanzetta P, Sarao V, Gregori G, Cagini C, Eandi CM, Carnevali A, Scorcia V, Maggio E, Pertile G, Costagliola C, Cennamo G, Mora P, Dell'Omo R, Affatato M, Passamonti M, Parravano M, Lassandro NV, Nassisi M, Viola F, Castellino N, Cappellani F, Giannaccare G, Boscia F, Grassi MO, Musetti D, Folegani V, Invernizzi A, Rossetti L, Bacci T, Ricci F, Lombardo M, Romano M, Valsecchi N, Coppola M, Cavarzeran F.   +53 more
europepmc   +1 more source

The evolving role of artificial intelligence in optimizing treatment and patient selection in diabetic macular edema. [PDF]

Indian J Ophthalmol
Ratra D, Rajalakshmi R, Suchetha M, Relan D, Deepikasri JS, Sathishkumar S, Ratra A.   +6 more
europepmc   +1 more source

Biomarkers of Diabetic Macular Edema on Optical Coherence Tomography After Cataract Surgery. [PDF]

J Vitreoretin Dis
Tran T, Goh J, Rogers S, Qureshi S, Lim LL.   +4 more
europepmc   +1 more source

Artificial Intelligence Driven Adjusted OCT-Based Classification System for Diabetic Macular Edema (AIDME). [PDF]

Clin Ophthalmol
Abreu-González R, Quezada-Peralta G, Udaondo P, Gil-Hernández MA, Donate-López J.   +4 more
europepmc   +1 more source

Concurrent vitrectomy with phacoemulsification for subclinical diabetic macular edema: a long-term comparative study. [PDF]

Graefes Arch Clin Exp Ophthalmol
Suzuki T, Tachi N, Tate H, Okamoto Y, Tanaka N, Masuko A, Nagahara M, Hayashi K, Terao R, Ueta T, Honjo M, Ueta Y.   +11 more
europepmc   +1 more source

Association of early anti-VEGF Therapy anatomical response with renal function and OCT biomarkers in diabetic macular edema. [PDF]

BMC Ophthalmol
Chen H, Shang Y, Yang P, Zhou Y, Yuan Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Diabetic macular edema

Disease-a-Month, 2021
Diabetic retinopathy (DR) is a leading cause of preventable blindness world-wide. Diabetic macular edema (DME) is the most common cause of moderate vision loss in patients with diabetes. Although treatments for DME have improved significantly over the past decades, the burden of this disease remains high for patients and the healthcare system alike ...
Melissa, Ixcamey, Camille, Palma
semanticscholar   +5 more sources

Treatment of Diabetic Macular Edema

Current Diabetes Reports, 2019
Diabetes mellitus is a global epidemic which is growing in prevalence, and diabetic macular edema (DME) is a leading cause of visual impairment among patients affected by this disease. Our objective is to review current and upcoming therapeutic approaches to DME.Once considered the gold standard in treatment of DME, focal/grid laser is now reserved ...
Eric J, Kim, Weijie V, Lin, Sean M, Rodriguez, Ariel, Chen, Asad, Loya, Christina Y, Weng   +5 more
openaire   +3 more sources

First-line treatment algorithm and guidelines in center-involving diabetic macular edema

European Journal of Ophthalmology, 2019
Management of center-involving diabetic macular edema represents a real therapeutic challenge. Diabetic macular edema is the leading cause of visual acuity impairment in diabetic patients.
Alfredo Garcia-Layana, Sumit Singh, Thibaud Mathis   +2 more
exaly   +2 more sources